HK1200101A1 - Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them - Google Patents
Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them Download PDFInfo
- Publication number
- HK1200101A1 HK1200101A1 HK15100547.1A HK15100547A HK1200101A1 HK 1200101 A1 HK1200101 A1 HK 1200101A1 HK 15100547 A HK15100547 A HK 15100547A HK 1200101 A1 HK1200101 A1 HK 1200101A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- baclofen
- memantine
- day
- obesity
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1100615A HU230263B1 (hu) | 2011-11-07 | 2011-11-07 | Memantin és baclofen hatóanyagokat tartalmazó kombinációs készítmény |
| HUP1100615 | 2011-11-07 | ||
| PCT/HU2012/000119 WO2013068774A1 (en) | 2011-11-07 | 2012-11-06 | Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1200101A1 true HK1200101A1 (en) | 2015-07-31 |
Family
ID=89990495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15100547.1A HK1200101A1 (en) | 2011-11-07 | 2012-11-06 | Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20140316007A1 (enExample) |
| EP (1) | EP2776019A1 (enExample) |
| JP (1) | JP2014532752A (enExample) |
| KR (1) | KR20140090203A (enExample) |
| CN (1) | CN103930099A (enExample) |
| AU (1) | AU2012335358A1 (enExample) |
| BR (1) | BR112014010892A2 (enExample) |
| CA (1) | CA2853872A1 (enExample) |
| CL (1) | CL2014001167A1 (enExample) |
| CO (1) | CO6970599A2 (enExample) |
| CR (1) | CR20140264A (enExample) |
| CU (1) | CU20140052A7 (enExample) |
| EA (1) | EA201490935A1 (enExample) |
| HK (1) | HK1200101A1 (enExample) |
| HU (1) | HU230263B1 (enExample) |
| IL (1) | IL232232A0 (enExample) |
| IN (1) | IN2014KN01142A (enExample) |
| MX (1) | MX2014005499A (enExample) |
| NI (1) | NI201400039A (enExample) |
| PE (1) | PE20141576A1 (enExample) |
| PH (1) | PH12014500979A1 (enExample) |
| SG (1) | SG11201401693UA (enExample) |
| WO (1) | WO2013068774A1 (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040102525A1 (en) * | 2002-05-22 | 2004-05-27 | Kozachuk Walter E. | Compositions and methods of treating neurological disease and providing neuroprotection |
| CN101500610A (zh) * | 2006-08-11 | 2009-08-05 | 国立大学法人名古屋大学 | 抗肥胖药及其利用 |
| EP2058008B1 (en) * | 2006-08-11 | 2013-08-21 | National University Corporation Nagoya University | Anti-obesity agent and use thereof |
-
2011
- 2011-11-07 HU HU1100615A patent/HU230263B1/hu unknown
-
2012
- 2012-11-06 US US14/356,096 patent/US20140316007A1/en not_active Abandoned
- 2012-11-06 HK HK15100547.1A patent/HK1200101A1/xx unknown
- 2012-11-06 IN IN1142KON2014 patent/IN2014KN01142A/en unknown
- 2012-11-06 SG SG11201401693UA patent/SG11201401693UA/en unknown
- 2012-11-06 KR KR1020147012752A patent/KR20140090203A/ko not_active Withdrawn
- 2012-11-06 BR BR112014010892A patent/BR112014010892A2/pt not_active Application Discontinuation
- 2012-11-06 EA EA201490935A patent/EA201490935A1/ru unknown
- 2012-11-06 CA CA2853872A patent/CA2853872A1/en not_active Abandoned
- 2012-11-06 PH PH1/2014/500979A patent/PH12014500979A1/en unknown
- 2012-11-06 MX MX2014005499A patent/MX2014005499A/es unknown
- 2012-11-06 AU AU2012335358A patent/AU2012335358A1/en not_active Abandoned
- 2012-11-06 EP EP12795610.0A patent/EP2776019A1/en not_active Withdrawn
- 2012-11-06 CN CN201280054371.7A patent/CN103930099A/zh active Pending
- 2012-11-06 PE PE2014000619A patent/PE20141576A1/es not_active Application Discontinuation
- 2012-11-06 JP JP2014540561A patent/JP2014532752A/ja active Pending
- 2012-11-06 WO PCT/HU2012/000119 patent/WO2013068774A1/en not_active Ceased
-
2014
- 2014-04-24 IL IL232232A patent/IL232232A0/en unknown
- 2014-04-29 CU CU2014000052A patent/CU20140052A7/es unknown
- 2014-05-05 CL CL2014001167A patent/CL2014001167A1/es unknown
- 2014-05-05 NI NI201400039A patent/NI201400039A/es unknown
- 2014-05-29 CO CO14116553A patent/CO6970599A2/es unknown
- 2014-06-04 CR CR20140264A patent/CR20140264A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140316007A1 (en) | 2014-10-23 |
| PE20141576A1 (es) | 2014-11-06 |
| SG11201401693UA (en) | 2014-05-29 |
| JP2014532752A (ja) | 2014-12-08 |
| PH12014500979A1 (en) | 2014-06-09 |
| HU230263B1 (hu) | 2015-11-30 |
| MX2014005499A (es) | 2015-02-20 |
| HUP1100615A2 (en) | 2013-06-28 |
| CN103930099A (zh) | 2014-07-16 |
| CO6970599A2 (es) | 2014-06-13 |
| CR20140264A (es) | 2014-07-11 |
| EP2776019A1 (en) | 2014-09-17 |
| IL232232A0 (en) | 2014-06-30 |
| CA2853872A1 (en) | 2013-05-16 |
| KR20140090203A (ko) | 2014-07-16 |
| EA201490935A1 (ru) | 2014-08-29 |
| CU20140052A7 (es) | 2014-07-30 |
| IN2014KN01142A (enExample) | 2015-10-16 |
| WO2013068774A1 (en) | 2013-05-16 |
| CL2014001167A1 (es) | 2014-07-04 |
| AU2012335358A1 (en) | 2014-05-29 |
| NI201400039A (es) | 2014-10-02 |
| BR112014010892A2 (pt) | 2017-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stahl | Dextromethorphan/bupropion: a novel oral NMDA (N-methyl-d-aspartate) receptor antagonist with multimodal activity | |
| Kapfer et al. | Nefopam and ketamine comparably enhance postoperative analgesia | |
| Raffa et al. | Does ‘strong analgesic’equal ‘strong opioid’? Tapentadol and the concept of ‘µ-load’ | |
| WO2016125108A1 (en) | Bilayer pharmaceutical composition for the treatment of obesity | |
| AU2010306114B2 (en) | Compositions comprising tramadol and celecoxib in the treatment of pain | |
| US20200330406A1 (en) | Compositions and methods for treating respiratory depression with fenfluramine | |
| US11000519B2 (en) | Pridopidine for treating drug induced dyskinesias | |
| AU2016266432B2 (en) | Compositions for use in treating Parkinson's disease and related disorders | |
| Heal et al. | What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials: Clinical Research | |
| US20220096491A1 (en) | Compositions and methods for treating alzheimer's disease and parkinson's disease | |
| US20210220308A1 (en) | Levodopa fractionated dose composition and use | |
| JPH06501713A (ja) | 認識障害を治療および予防するための５−ＨＴ↓１↓ａ−レセプター結合アンタゴニストまたは半アゴニストの使用 | |
| EP4034082A1 (en) | Oral pharmaceutical immediate release composition and method of treatment for weight loss | |
| WO2016005897A1 (en) | Combination of pregabalin and meloxicam for the treatment of neuropathic pain | |
| WO2010112530A1 (en) | Pipamperone and a second agent in treating mood and anxiety disorders | |
| WO2005110412A1 (en) | Neuroprotective properties of dextrorotatory morphinans | |
| US9610285B2 (en) | Compositions for controlling food intake and uses therefor | |
| CN103930099A (zh) | 美金刚胺和巴氯芬的治疗组合以及含有该组合的药物组合物 | |
| Munzar et al. | Enhancement of the discriminative stimulus effects of phencyclidine by the tetracycline antibiotics doxycycline and minocycline in rats | |
| Evenson et al. | Antinociceptive efficacy and safety of subcutaneous tramadol in chinchillas (Chinchilla lanigera) | |
| EP3253379A1 (en) | Pharmaceutical composition for the treatment of obesity | |
| RU2506077C1 (ru) | Комбинация для профилактики, коррекции и терапии боли, связанной с нейродегенерацией или ассоциированной с соматоформными расстройствами | |
| US12036213B2 (en) | Pridopidine for treating drug induced dyskinesias | |
| US20180104236A1 (en) | Methods of treatment comprising administering a high daily dose of oxycodone and naloxone in a 2:1 weight ratio | |
| Auro-Atorvastatin et al. | LIPID METABOLISM REGULATOR |